FDA.reportPublic FDA data

POLOXAMER 407

Substance profile for UNII TUF2IVW3M2, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
TUF2IVW3M2
Preferred term
POLOXAMER 407
Registry number
691397-13-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
155155
PubChem
0
NCIt
C84071
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm155155mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=155155
NCI ThesaurusC84071ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84071
FDA Substance Registration SystemTUF2IVW3M2precision.fda.gov/uniisearch/srs/unii/TUF2IVW3M2

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
DRUG FACTS2
DRUG FACTS2
GABAPENTIN2
DZA Brands, LLC Children’s Allergy Drug Facts3
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
beb24f57-87d5-4c86-9de4-09766ccc57d91
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
ShopRite Sleep-Aid Drug Facts2
DRUG FACTS1
9c0c5b19-a6fb-434e-a319-eba1d9b04cf11
P1P Magic Whitening & Antiaging1
Error: java.lang.NoClassDefFoundError: net/sf/saxon/TransformerFactoryImpl4
Dendracin Neurodendraxcin®, Topical Pain Relief Lotion1
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE delayed-release capsules USP, for oral use INITIAL U.S. APPROVAL: 19891
P1P Mela Care2
P1P Skin Rebirth Cream1
Air-Vita Allergy2
Colgate ® Total ® Advanced Pro-Shield™ Mouthwash Spearmint Surge™1
DZA Brands, LLC Sleeptime Drug Facts2
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
These highlights do not include all the information needed to use raloxifene hydrochloride tablets, USP safely and effectively. See full prescribing information for raloxifene hydrochloride tablets, USP. Raloxifene Hydrochloride Tablets, USP for Oral Use Initial U.S. Approval: 19971
3d855db4-b10f-474b-88fc-fdade8a8226e3
8eae4995-5905-4269-8d53-e7acb54856a31
DRUG FACTS1
DRUG FACTS1
Clear 2 in 1 Scalp Comfort Anti Dandruff Shampoo and Conditioner2
Clear Men Cool Sport Mint Anti Dandruff Shampoo PDP and drug facts box2
Clear Complete Care Nourishing Anti Dandruff Shampoo PDP and drug facts box1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
Oral Dent Amber3
Oral Dent Citrus2
Oral Dent Fresh Mint2
Oral Dent Blue Mint2
Buenos Dias de Personna cool mint1
Buenos Dias de Personna mint1
Buenos Dias de Personna original1
Oral Dent Amber1
Oral Dent Blue Mint1
Oral Dent Citrus1
Oral Dent Fresh Mint1
Drug Facts7
DRUG FACTS1
DRUG FACTS1
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
Drug Facts1
Clear Men Ocean Mineral Anti Dandruff Shampoo and Conditioner1
Clear Men Deep Clean Hydration Anti Dandruff Shampoo1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
Gabapentin Tablets, USP 600 mg and 800 mg Allied Pharma Inc5
DRUG FACTS1
Drug Facts1
Dendracin Neurodendraxcin®, Topical Pain Relief Lotion1
Gabapentin Tablets USP2
These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS ® (raltegravir) Film-Coated Tablets, for oral use ISENTRESS ® (raltegravir) Chewable Tablets, for oral use Initial U.S. Approval: 20072
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
Drug Facts2
Drug Facts2
Drug Facts2
Oral Defense Fluoride Rinse12
Drug Facts2
Drug Facts2
Drug Facts2
Drug Facts3
Drug Facts2
9f9f36e7-ec66-473d-af17-09d4b492ded51
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
Drug Facts3
84f14898-dbdc-408e-a521-c88fd8290f4b1
Oral Defense Mouth Rinse17
Clear Complete Care Anti Dandruff Shampoo PDP and drug facts box1
Clear Men 2 in 1 Complete Care Anti Dandruff Shampoo and Conditioner PDP and drug facts box1
Clear Men 2 in 1 Dry Scalp Hydration Anti Dandruff Shampoo and Conditioner PDP and drug facts box1
Gabapentin Tablets USP3
Drug Facts2
Drug Facts2
Drug Facts1
Drug Facts1
Drug Facts1
Drug Facts1
These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS ® (raltegravir) Film-Coated Tablets, for oral use ISENTRESS ® (raltegravir) Chewable Tablets, for oral use Initial U.S. Approval: 20072
Gabapentin Tablets USP4
Dendracin Neurodendraxcin®, Topical Pain Relief Lotion2
Drug Facts2
Drug Facts2
Drug Facts2
8a023942-01e8-4849-aa3c-1a640ffc7fd37
ebd0feb6-b6b8-4ad6-9896-4bf62f4359881
ec5a5404-dc36-4e94-b6d9-c2ef38a2a07c1
ba5c415e-2a44-4b49-b85a-55984e3131b83
Drug Facts2
Drug Facts2
d8dd70ed-37e2-4c7c-9676-dcedf7e3d5cd1
Drug Facts1
Drug Facts3
kolorz Sixty Second Fluoride Foam Cherry Cheesecake1
kolorz Sixty Second Fluoride Foam Blue Raspberry1
kolorz Sixty Second Fluoride Foam Triple Mint1
Fluoride Tooth Polish Cool Mint Content of Label1
Sulfacetamide Sodium and Prednisolone Sodium Phosphate Ophthalmic Solution1
These highlights do not include all the information needed to use ZMAX safely and effectively. See full prescribing information for ZMAX. ZMAX (azithromycin) powder, for suspension for oral use Initial U.S. Approval: 19911
drug facts1
Drug Facts1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII TUF2IVW3M2 page 1 of 1 · 15 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
POLOXAMER 407TUF2IVW3M2691397134SUSPENSIONINTRATYMPANIC63 mg
POLOXAMER 407TUF2IVW3M2691397134GELOPHTHALMIC1 mg
POLOXAMER 407TUF2IVW3M2691397134SOLUTIONOPHTHALMIC0.2 %w/v
POLOXAMER 407TUF2IVW3M2691397134SUSPENSION/ DROPSOPHTHALMIC1 mg
POLOXAMER 407TUF2IVW3M2691397134CAPSULEORAL468 mg
POLOXAMER 407TUF2IVW3M2691397134CAPSULE, DELAYED RELEASEORAL5 mg
POLOXAMER 407TUF2IVW3M2691397134CAPSULE, EXTENDED RELEASEORAL40 mg
POLOXAMER 407TUF2IVW3M2691397134POWDER, FOR SUSPENSIONORAL0.01 mg
POLOXAMER 407TUF2IVW3M2691397134SOLUTIONORAL50 mg/5ml
POLOXAMER 407TUF2IVW3M2691397134SUSPENSIONORAL10 mg
POLOXAMER 407TUF2IVW3M2691397134TABLETORAL495 mg
POLOXAMER 407TUF2IVW3M2691397134GELPERIODONTAL155 mg
POLOXAMER 407TUF2IVW3M2691397134CREAMTOPICAL13 mg
POLOXAMER 407TUF2IVW3M2691397134GELTOPICAL28 mg
POLOXAMER 407TUF2IVW3M2691397134LOTIONTOPICAL71 mg